News & Views

Press Releases

Population Council to Determine Feasibility of Fast-Tracking Oral Contraceptive Multipurpose Prevention Technology (cMPT) Development

NEW YORK, NEW YORK (November 14, 2018)  ̶  The Population Council has received initial funding from the Children’s Investment Fund Foundation (CIFF) to assess the feasibility of combining oral pre-exposure prophylaxis (PrEP) for HIV prevention with an oral contraceptive into a single pill, which women would take once a day.

Read more

Press Releases

The Population Council’s Régine Sitruk-Ware Named By TIME Magazine As One of 50 Most Influential People in Health Care of 2018

The Population Council’s Régine Sitruk-Ware Named By TIME Magazine As One of 50 Most Influential People in Health Care of 2018
Photo credit: TIME Magazine

New York, NY, 18 Oct. 2018 – Régine Sitruk-Ware, MD, distinguished scientist at the Population Council’s Center for Biomedical Research, has been named by TIME Magazine as one of the 50 Most Influential People in Health Care of 2018. Dr. Sitruk-Ware is being recognized for her research and leadership, which led to the recent U.S. FDA approval of Annovera™ (segesterone acetate and ethinyl estradiol vaginal system), the first and only contraceptive that provides an entire year of protection against unintended pregnancy while fully under a woman’s control. 

Read more

Press Releases

New Research on Griffithisin and Carageenan to Prevent HIV and STIs Published in Nature Communications

September 24, 2018 – New research by the Population Council and partners shows that it may be possible to formulate a discreet, convenient, and woman-controlled multi-purpose technology to prevent HIV and other sexually transmitted infections (STIs) with limited risk of cross-resistance to antiretrovirals (ARV). This research published today in Nature Communications tests the non-antiretroviral agents, griffithsin (GRFT) and carrageenan (CG), in a fast-dissolving vaginal insert in rhesus macaques and mice.

Read more

Press Releases

FDA Approves the First One-Year Contraceptive Fully under a Woman’s Control

The Population Council, a global nonprofit research organization, announced it has received U.S. Food and Drug Administration (FDA) approval for Annovera™ (segesterone acetate and ethinyl estradiol vaginal system), the first and only contraceptive that provides an entire year of protection against unintended pregnancy while fully under a woman’s control. The approval marks an important step toward expanding contraceptive options for women.

Read more

Press Releases

Jonathan Shakes Joins Population Council Board of Trustees

The Population Council announces the appointment of Jonathan Shakes to the Board of Trustees. Mr. Shakes is an e-commerce logistics consultant, having worked fifteen years in operations, software and product management at Amazon and its subsidiaries.

Read more

Press Releases

Population Council’s One-Year Contraceptive Ring Advances to FDA Review

The Population Council today announced that the U.S. Food and Drug Administration (FDA) has accepted for review its one-year Nestorone® / ethinyl estradiol vaginal ring for pregnancy prevention. If approved, the contraceptive vaginal ring would be the first contraceptive option that provides a full year of protection against unintended pregnancy while fully under a woman’s control.

Read more

Press Releases

Esteemed Dr. Salim S. Abdool Karim Joins Population Council Board of Trustees

The Population Council announces the appointment of leading South African AIDS researcher, Salim S. Abdool Karim, to the Council Board of Trustees. Dr. Karim, a clinical infectious diseases epidemiologist is the Director of the Centre for the AIDS Programme of Research in South Africa (CAPRISA), CAPRISA Professor of Global health at Columbia University in New York and Honorary Pro Vice-Chancellor (Research) at the University of KwaZulu-Natal. 

Read more